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1. Introduction 
 
The metabolite patterns in healthy and also in pathological brain can be determined with 
in vivo quantitative proton MR spectroscopic (1H MRS) measurement. With clinical MR 
scanners molecules can be measured that consist hydrogen atoms with chemical bonds in 
forms of metin (–CH), methylene (–CH2) and methyl (–CH3) moieties. The proper level of 
quantification is very important in the application of in vivo MRS. 
Quantitative measurements of metabolite concentrations would be of great 
importance as they would permit the comparability of data between different research 
sites and would also overcome the assumption that at least one metabolite concentration 
should be constant in the relative metabolite ratio approach. The main reason why 
absolute quantification of MR-visible metabolites is not widespread is the sometimes 
complicated technical or theoretical background necessary for the measurements. 
Depending on the number of required corrections (T1, T2, B1 etc.) during the MR 
spectroscopic measurement, data processing and calibration, comparison can be carried 
out in different levels of “absolute quantitative measurement”. In case of good 
reproducibility a sequence- and scanner specific semi-quantitative results of the 
measurements can be specified in the so-called “institutional units”. If the comparison 
between spectroscopic results and other methods is needed or we have to use the 
resulting concentration in the kinetic and thermodynamic equation, the use of standard 
biochemical units is required. Squarely it would lead to improvement to work out a 
measurement and evaluating method that does not need difficult correction steps making 
it possible for professional radiographers to do the measurements in everyday clinical 
practice. 
 
Possible ways of the evaluation of MR spectroscopy 
There are three main steps of quantitative spectroscopy: data collection (which includes 
localization), data processing (including model fitting) and calibration (change to 
standard units of concentration). In the latter the amount of metabolites signal must be 
defined in the spectrum, taken into account the number of protons of the given 
metabolite. 
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Depending on the number of necessary correlations (T1, T2, B1 etc.) during the MR 
spectroscopic measurement, data processing and calibration, comparison can be carried 
out at different levels of “absolute quantitative measurement”. In case of good 
reproducibility such a sequence and scanner-specific semi-quantitative results of the 
measurement can be specify in the so called “institutional units”. If the comparison of 
spectroscopic results and other applied methods necessary or we have to use the 
resulting concentration in the kinetic and thermodynamic equation, the use of standard 
biochemical units required. 
If we apply appropriate levels of correction during the measurement and 
postprocessing (B1, B2 inhomogenity, T2 relaxation, partial volume effect, phase and base 
line correction etc.) than the area under the peaks will be precise enough and can be 
reproduced well. By comparing it with and external and internal reference we get the 
absolute concentration value. 
During the measurements and spectra postprocessings steps theoretically it is possible 
to correct all sources of errors. In clinical practice in most of the cases it is not reasonable 
and there is no time for it. The more disturbing factors we can consider, the more precise 
the results of our measurements will be, at the same time we will be able to detect smaller 
and smaller changes of metabolic concentrations.  
Different technical approaches of quantitative evaluation of MR spectroscopic 
measurement are known, that generally permit the quantitative determination of 
chemical substances with the application of a reference inside from the body (internal) or 
outside from the body (external). The advantage and disadvantages of both approaches 
are known. With the application of an internal reference the annoying parts of the 
necessary calibration and correction steps of external reference methods can be 
substituted with use of a proper internal reference, because of measurement conditions 
are the same for metabolites spectra and for reference substrates. 
To avoid quantifications we have to determine the actual quantity of substrate applied 
as an internal reference. Water is a good candidate because of high amount of water in 
the brain. High signal-to-noise ration of water in MRS and MRI makes possible to 
separate liquor from intracellular water in the measured voxel, avoiding the effects of 
extracellular water compartments. 
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In vivo brain water content determination 
For in vivo brain water content determination computer tomography was applied in the 
first experiments. Available physical parameters with MR imaging (for e.g. T1, T2, proton 
density) are also appropriate for brain water content determination. 
FATOUROS and his colleagues developed a theory that explains the relationship 
between T1 relaxation time and brain water content. FATOUROS and MARMAROU 
determined these formulas on the basis of fast exchange two-state model, that implies the 
interchange between free water molecules and bound hydration water fraction is 
sufficiently fast. T1 relaxation time of the given tissue is the weighted average of T1 
relaxation times of free water and bound hydration water. We can assume that the total 
water content has a dominant role in relaxation processes and thus the tissue water 
content at any field strength can be estimated based on T1 relaxation time (Equations 1-3). 
l/ƒw=ax+b/T1 Equation 1 
l/ƒw=0,935+0,283/T1; at 1T field strength Equation 2 
l/ƒw=0,921+0,341/T1; at 1.5T field strength Equation 3 
Where ƒw: percentage water concentration [%], that needed for the water map; T1: 
measured T1 relaxation time [s]; ’a’ and ’b’: field strength and tissue hydration fraction 
dependent constants. (at 1T field strength a=0.935 and b=0.283; at 1.5T field strength 
a=0.921 and b=0.341). 
 
 
2. Aims 
 
According to the previously identified and described results in the literature our aims 
were the following: 
1. To use brain water as an international reference for quantification of MR spectroscopic 
measurement. 
1.a. At first it was necessary to validate the relationship between the T1 relaxation 
time of water and brain water content at 1.5T―that was previously validated at 
1T by others. 
1.b. We would like to determine the water content of a given area of the brain with 
MR spectroscopy applying the validated relationship. 
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1.c. In addition we used T2 relaxation time analysis to correct tissue water content 
with the extracellular fraction. Further more the resulting water content was 
used as an internal reference to quantitative MR spectroscopic measurement of 
metabolite concentration. 
2. Magnetic field strength is the main determinative factor in the resolution, the signal-to-
noise ratio and also the quality of MR spectroscopy. During the last years 3T MR scanners 
have been installed in Hungary, so the previously developed quantitative MR 
spectroscopic method at 1.5T field strength seemed appropriate to adopt at 3T field 
strength, because routine diagnostic use of quantitative MR spectroscopy has not been 
available yet. 
2.a. For this calibration of water content measurement was necessary at 3T field 
strength. 
 
 
3. Materials and methods 
 
Measurements at 1.5 Tesla field strength 
Materials 
A total of eight healthy male volunteers (27-43 years, mean age 32±6,1 years) were 
involved in the study. 
 
Methods—MR measurements 
The examinations were performed at the Diagnostic Centre of Pécs on a whole-body 1T 
(Siemens Harmony Impact; Siemens, Erlangen, Germany) and in Kaposvár University, 
Institute of Imaging and Radiation Oncology on a whole-body 1.5T (Siemens Magnetom 
Avanto; Siemens, Erlangen, Germany) MR scanner. A standard circularly polarized head 
coil at 1T and a phased-array receive-only head matrix coil at 1.5T were used. 
The relaxation times T1 and T2 of water were measured at each field strength, using the 
same voxel size (20×20×20mm3) and position. To achieve identical voxel positioning in 
the same subject in the different scanners, the anterior and posterior commissure (AC-PC) 
line was determined in each measurement session on a T1-weighted high-resolution 
midsagittal localizer scan. Voxel positioning in the gray and white matter was performed 
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in an axial slice for the same distance and rotation relative to the AC-PC line, using a 
turbofast low-angle shot (FLASH) sequence with a slice thickness of 20mm. 
The relaxation time T1 was measured with an array of TRs (time of repetition) (940, 
1300, 1700, 2400, and 4000 ms at 1T, and 1300, 1500, 3000, and 4000 ms at 1.5T). T2 was 
likewise determined with an array of TEs (30, 100, 200, 400, 600, 800, 1000, 1200, and 
1500 ms at 1T, and 20, 50, 80, 110, 140, 170, 200, 230, 270, and 300 ms at 1.5T). Other 
parameters of the applied stimulated echo acquisition mode (STEAM) sequence were 
identical: TR=6000 ms (T2 measurement), TE=20ms (T1 measurement), mixing time 
(TM) = 10 ms, preparation scans = 2, and acquisition = 1. 
Water-suppressed scans (chemical shift-selective [CHESS] pulse, bandwidth = 35Hz) 
were collected only at 1.5T for metabolite concentration measurements with the following 
parameters: TR/TE/TM/acquisitions/voxel size = 6000ms/20ms/10ms/64/ 
20×20×20mm3. The effects of both T1 and T2 on the spectra obtained with these 
parameters can be neglected, due to the short TE and TM, and sufficiently long TR.  
The total measurement time for a single voxel was 10 minutes 6 seconds. 
 
Data processing 
Spectroscopic raw data were post processed explicitly by using the Siemens Syngo-
Spectroscopy software for spectroscopic analysis. We applied a Hanning filter and zero 
filling to 2048 data points before Fourier transformation. After baseline and phase 
correction, an automatic fit was applied to Fourier-transformed spectra, and the peak 
integrals of water, choline, creatine, and N-acetyl-aspartate were determined. The T1 and 
T2 values of water were obtained from the exponential fit (nonlinear least squares with 
Trust-Region algorithm) of the water peak integrals as a function of TR or TE, 
respectively. 
The fraction of the slowly-relaxing component in the T2 measurement was assigned to 
the CSF (fCSF), and was used to correct for the partial volume effect in the quantification of 
the absolute metabolite concentration. 
The MCW can be calculated (Equation 4) from the ratio of tissue water (ƒW) and the 
molar concentration of water (55.6mol/l). 
C=Im×MWC×2/(n×Iw)/(1–fLIQU) Equation 4 
Where C: molar concentration of the metabolite [mmol/l]; Im: peak integral of a given 
metabolite; 2: it marks the number of the induced protons; MWC: molar tissue water 
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content was calculated from ƒw and the molar concentration of pure water 
(MWC=55.6mol/l×ƒw); n: number of resonating protons; Iw: peak integral of water 
extrapolated to TE=0; ƒLIQU: proportion of water in the liquor/100. 
 
Measurements at 3 Tesla field strength 
Materials 
A total of six healthy volunteers (22±2 years) were involved in the study. 
 
Methods—MR measurements 
The examinations were performed at the Diagnostic Centre of Pécs on a 1T Siemens 
Harmony (Erlangen, Germany) and a 1.5T Siemens Magnetom Trio A Tim System 
(Erlangen, Germany) MR scanner. A standard circularly polarized head coil at 1T and a 
phased-array head coil at 3T were used also CP mode. 
As a first step of calibration at 1T and 3T field strengths T1 relaxation time 
measurements were performed in a given axial slice of the brain determined by anterior 
and posterior commissure (AC-PC) with identical position, resolution and slice thickness 
(FOV=220×200mm2; matrix resolution 128×128; slice thickness 15mm). According to the 
literature determination of AC-PC-line insures good reproducibility. For example on this 
basis, stereotactic neurosurgical interventions planned and carried out with millimeter 
accuracy. 
We used a turbo flash sequence at 1T field strength with eight different time of 
inversion (TI), with the following parameters: (TR/TE=10,000ms/1.4ms; TI=200, 300, 500, 
800, 1300, 1800, 3500, 6000ms. The time of acquiring an image was 30 seconds, and the 
measurement with the 8 TI took individually 4 minutes. 
Fitting of T1 times was performed for each voxels of the selected slice according to the 
Equations 2 with Matlab R2007 programme. We converted the resulting T1 values into a 
gray scale image to get a T1 map. T1 times at 3T were determined with a turbo spin echo 
sequences applying six different times of inversion; the previous calibration of the 
method was performed with phantom measurements. Parameters of the sequence: 
TR/TE=3000ms/11ms; TI=300, 600, 900, 1400, 2000, 2800ms. The measurement time was 
45s; the full time was 4.5 minutes. We fitted the T1 times with the help of the Equation 3 
voxel by voxel and then we got the T1 map; where I: intensity; A and B: constants 
(include I0); TI: time of inversion [ms]; T1: T1 time [ms]. 
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T1 relaxation times and water content calibration 
In the next step we correlated the calculated water content in every voxel acquired at 1T 
field strength to the T1 values in homologue voxels at 3T. We found the following 
relationship between brain water content and T1 relaxation time at 3T field strength 
(Equation 5). 
ƒw[%]= (T1+1217)/31.85 Equation 5 
Applying this relationship at T1 maps can be converted in to water map at 3T as well. 
The water map represents the water content in percentage. According to the relationship 
of that we set up, the brain water content can be determined at 3T field strength with T1 
measurement precisely. 
 
Practical use of quantitative spectroscopy based on brain water content measurement at 3T 
With the previously described MR spectroscopic method at 1.5T, the metabolite 
concentration of the brain can be determined. For this, we use the measured brain water 
content as an internal reference, that can be calculated using the correlation that we 
described (Equation 5). In the future it can be used at 3T field strength equipment. 
 
Measurement of proton spectrum 
Voxels were placed in the frontal white matter for the measurement of the white matter, 
and in the occipital gray matter for the measurement of gray matter. During the 
spectroscopic measurement we used water suppressed (CHESS) PRESS sequences at 3T 
field strength. 
Spectra were measured with long repetition time (6000ms) and the shortest possible 
echo time (30ms) to reduce the effect of T1 and T2 weightening to minimum in the 
spectrum. The size of the measured voxel was 15×15×15m2, the number of averaging 
were 96, the receiver bandwidth was 1200Hz/pixel. 
Spectrum postprocessing was carried out Siemens Leonardo Workstation. After 
Fourier transformation, phase and baseline correction, the program fitted the metabolite 
curves, giving the necessary metabolite integrals for concentration calculation. The next 
step was the determination of the area belonging to one proton under the curve for the 
calculation of quantity of the metabolites. This can be derived from the water signals and 
measured water content. 
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Measurement of water signal 
In each voxel we determined the integral of the water signal by the spectrum, that the 
concentration that belongs to this with T1 measurement. We measured the water signal 
with the same parameters as the metabolite spectrums, the difference was that the water 
suppression was not switched on. T1 measurement were performed with constant echo 
time and different repetition time: TR=6000, 5000, 4000, 3000, 2000, 1400, 900, 500ms; 
TE=30ms; bandwidth 2500Hz/pixel. 
The size and position of the voxel was identical with the metabolite spectrum 
measurement. T1 relaxation times were calculated with Matlab R2007 program, using 
water signal integrals measured with different repetition times. On the basis of T1 
relaxation times we determined the water content of the given white and gray matter 
areas. 
 
T2 measurement and concentration calculation 
Separation of brain tissue water and liquor water content was based on T2 relaxation time 
measurements. During T2 measurements different echo times were: 30, 60, 90, 120, 180, 
240, 400 and 800ms; TR was 3000ms. Other parameters were the same as in T1 
measurements. 
We determined the T2 relaxation times of the water content of the two compartments 
with Matlab R2007 using biexponential fitting. To the calculation of metabolite 
concentration we substituted the corrected integral of tissue water peak in to the relation 
introduced previously (Equation 4). 
 
 
4. Results 
 
Results at 1 and 1.5 Tesla field strength 
With the increase of field strength T1 relaxation time became longer. The calculated MWC 
proved to be slightly larger at 1.5T, despite the same voxel positioning. 
No biexponential signal decay was observed in the white matter voxels during the 
calculation of T1 relaxation time (i.e., no CSF fraction), whereas the gray matter voxels 
demonstrated the same fCSF at the two field strengths, indicating good reproducibility 
(10 ± 3% at 1T and 12 ± 4% at 1.5T, P=.3). The fit of functions applied to T1 and T2 
calculations was nearly perfect with correlation coefficients of R2<.99 in each case. 
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In our study, the concentration of N-acetyl-aspartate in the gray matter 
(14.02±1.93mmol/l) was higher (P<.05) than that in the white matter (11.08±2.24mmol/l). 
We found a significantly higher (P<.001) concentration of creatine in the gray matter 
(9.98±1.03mmol/l) as compared with that in the white matter (7.83±0.66mmol/l). The 
difference in concentration of choline between the white matter (2.05±0.38mmol/l) and 
the gray matter (1.14±0.24mmol/l) voxels was also significant (P<.001). 
 
Results at 3 Tesla field strength 
The water content of each voxels in the water map made at 1T field strength were 
correlated with the T1 values of homologue voxels measured at 3T field strength. 
The strength of the linear correlation of water content and T1 relaxation time is given 
by the correlation co-efficient (R2), that is R2=.8828 at this time. This is a very strong 
correlation and it proves the solidity and precision of the fitting. The parameters of the 
fitted line: a=31.85±0.6% and b=-1217±1.0%; according to the y=ax+b correlation 
(Equation 6). 
ƒw[%]= (T1+1217)/31.85 Equation 6 
The measured T1 relaxation times, compare to the results at 1T field strength, are 
longer. Water content values in the white matter are similar to that in the literature 
(67.6% vs. 68%), but our method resulted in a higher water content compare to literature 
data (83.5% vs. 80%). 
Our gray matter results showed high variations may be because of partial volume 
effects. According to the applied voxel size (15×15×15mm) the measured volume 
inadvertently contains different volumes of white matter in every examination. The 
applied voxel position―the gray matter of parietooccipital region―is an accepted place 
for measurement of the gray matter. 
The received molar tissue water content at 3T field strength of the gray matter is 
higher than at 1 and 1.5T, in the white matter it was lower than at 1 and 1.5T. 
According to the biexponential T2 relaxation time fitting contrary to the measured data 
at 1T and 1.5T biexponential fitting was successful in white matter, with high rate of 
deviation. In gray matter at 3T field strength the fraction of liquor water was smaller than 
at 1T and 1.5T field strength. 
To correlate results to the measured data at 1.5T field strength it was smaller at 3T 
field strength. In our method there were no significant differences (7.79±0.67mmol/l vs. 
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8.20±0.45mmol/l) between NAA concentration in the white matter and in the gray 
matter. Creatine concentration was significantly (P<.05) smaller in white matter 
(3.76±0.28mmol/l) than in gray matter (4.76±0.18mmol/l). Choline concentration was 
also significantly (P<.05) different (3.68±0.47mmol/l vs. 2.64±0.35mmol/l) in the 
measured voxels, but in this case it was significantly smaller in gray matter. Mio-inozitol 
was present in significantly (P<.05) higher concentration in white matter 
(10.35±3.7mmol/l) than in gray matter (8.32±1.42 mmol/l). 
 
 
5. Discussion 
 
For the quantification of MR spectroscopic measurement there are many methods in the 
literature, the two main groups are the internal and external references. Water was 
applied as an internal reference previously, and an automatized protocol was developed 
based on the assumption of the water content of gray and white matter. Brain water 
content can change in different ages and in different pathological states. The relationship 
found by FATOUROS and his colleges makes possible the brain water content 
determination based on the T1 value of water, that was validated at 1T field strength in 
different pathological states that increase the brain water content, for e.g. brain tumours 
and traumatic brain injuries. Our method yielded 40.53±0.57mol/l water content in white 
matter and 45.13±0.44mol/l in gray matter at 1.5T field strength based on T1 value 
determination. According to data at 3T field strength gray matter water content is slightly 
higher (46.4±1.5mol/l), white matter water content is slightly lower (37.6±0.5mol/l). Our 
results shows good correlation with other MR and gravimetric methods from the 
literature. 
Differences can be caused besides the different field strength, but can also one to the 
methods of T1 relaxation time determination. At 1.5T field strength we used the equation 
worked out by FATOUROS and MARMARON, that resulted a slightly but significantly 
higher water content values in white matter and gray matter compared to the validated 
results at 1T. Beside this we validated the correlation of T1 relaxation time and water 
content at 3T field strength with inversion time turbo flash sequences. 
Use of the measured water contents and the water peak integral at TE=0 for calibration 
gave metabolite concentrations lying nicely in the range obtained by the meta-analysis of 
MRS results. For example, at 1.5T field strength determined metabolite concentrations in 
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white matter (NAA 11.28±2.24mmol/l) are the same with the values of outer reference 
determination methods. Metabolite concentrations from the gray matter is more difficult 
to correlate with the results of the white matter, and also data from the literature varies, 
because of regional differences and various partial volume effects (white matter, liquor). 
In white matter voxels the biexponential fit of T2 relaxation curve was unsuccessful at 1T 
and 1.5T field strength. At 3T field strength fitting was successful-resulting in 2.65% 
small liquor fraction with high deviation (SD-value 2.51). Higher sensitivity at 3T field 
strength might explain detection of liquor water fraction. 
Measurement of T2 relaxation time permitted the extrapolation of water-signal to 
0 echo time, so water peak integral at 0 echo time showed the whole water content (the 
repetition time was long enough compared to T1 relaxation time). For metabolite 
determination we did not have to consider the effects of T2 relaxation time because of 
short echo time of MR-sequence applied. This is an accepted method in the literature 
(long enough repetition time for full T1 relaxation and short echo time to avoid T2 
relaxation effects). 
There are two limiting factors of the applied method, that are related to MR-visibility 
of brain water content and water content determination based on T1 relaxation time. The 
advantages of our method besides the two limiting factors, that there is no need for 
previous assumptions or difficult calibrations and special conditions that could prevent 
other methods of quantitative MRS from everyday use. 
In conclusion, to the best of our knowledge, this is the first work to propose 
quantitative proton MRS based on the water content as an internal reference determined 
by T1 measurement. We demonstrated, that the relationship between brain water content 
and T1 relaxation time can be applied in human in vivo quantitative MR spectroscopy at 
1.5T field strength. Metabolite concentrations, such as NAA, creatine, choline, mio-
inozitol, calculated in this way show good accordance with values of other methods from 
the literature. 
In MRS measurements higher field strength results in better signal-to-noise ratio also 
better peaks separation. The quality of the received spectrums is better, so the calculation 
of the peak integrals is more exact. During the application at 3T field strength the 
received metabolite concentration―in contempt of our exceptions―do not show good 
accordance with our previous results and also with data from the literature. 
The explore the reasons further examinations are required in the future. 
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The proposed method is simple and can readily be applied in any MR center without 
the need for complicated corrections or calibration procedures. 
 
Practical utilization of the results 
The possible applications of the method developed by us in clinical practice and research 
may include the diagnosis and monitoring conditions and diseases involving changes in 
brain water content.  
Our method that we applied on quantitative MR spectroscopy at 1.5T and 3T field 
strength can be used for examination of such conditions and diseases that do not affect T1 
relaxation time of brain tissue. In this way diffuse brain injury (for e.g. radiotherapy and 
toxic effects, the normal MR appearance of brain in multiplex sclerosis, psychiatric 
disorders) could be the possible fields of application. 
Scientific publications report of different application areas of quantitative MR 
spectroscopy with the application of other referencing methods: 
 Characteristic metabolite level changes were found in the group of psychiatric diseases 
with mild cognitive impairment. 
 In Duchenne muscular dystrophy decreased choline level were found in the 
cerebellum and in the temporoparietal region. The temporoparietal NAA 
concentration also showed mild but significant differences. The latter showed 
correlation with the patients’ cognitive function. 
 In childhood neurological processes, tumourous, inflammatory and infectious 
diseases, diseases affecting the white matter and in neonatal brain injury there are 
quantitative MRS applications. Differences of brain metabolite ratios proved to be 
important biomarkers and of prognostic value in prenatal hypoxia. 
 The quantitative MRS could be of help in differentiation of low-grade and high-grade 
gliomas on metabolic basis. 
 In multiple sclerosis conventional MR imaging shows brain leasions that show only 
partial correlation with the symptoms, progression and results of treatment. The 
quantitative MR techniques―including MRS―promote the understanding of the 
pathogenesis, the underlying processes of progression and the effects of treatment. 
 With quantitative MR measurement methods (MR voxel-based morphometry, 
diffusion tensor imaging, functional MRI and MR spectroscopy) neurobiological and 
biochemical changes were detected in some psychiatric diseases. MR spectroscopy can 
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detect metabolic differences in specific brain areas in schizophrenia, bipolar disorder, 
mood disorders (uni- and bipolar), major depression, anxiety disorders and attention 
deficit hyperactivity disorder. 
 In the corpus callosum decreased NAA concentration can be measured with 
quantitative MR spectroscopy and the differences detected in T2 relaxation times relate 
to the pathology of schizophrenia and supports the previous hypothesis of decreased 
connections/”disconnectivity” in corpus callosum. 
 To detect the effects of chemotherapy and radiation therapy on brain tissue a wide 
range of MR techniques were used; recently MR spectroscopy was also applied. 
Besides the differentiations of radiation necrosis from recurrent tumours, MR 
spectroscopy could play a role in the detection of changes in normal appearing brain 
tissue affected by the effects of radiation. 
 
 
6. New scientific results 
 
1. The previously validated correlation between T1 relaxation time and brain water 
content at 1T was applied at 1.5T accomplished by a spectroscopic method. In gray 
and white matter of the brain we got the same results about the water content as in 
literature. Tissue water content was corrected with extracellular fraction based on 
biexponential T2 relaxation time analysis. 
2. It was successfully demonstrated that water content of the voxel can be determined 
reliably. We used water content calculated from MR spectroscopic T1 relaxation time 
measurements at 1.5T, as an internal reference. We obtained metabolite 
concentrations in normal brain tissue equal with the previous data in the literature. 
3. Water content measurement at 3T was calibrated using the previously validated brain 
water content determination based on T1 relaxation time at 1T field strength. The 
coefficients of the equation about the relationship of T1 relaxation time and water 
content were determined at 3T filed strength. 
4. We used the measured water content as an internal reference to quantify MR spectra 
at 3T. 
5. The proposed method is simple and can readily be applied in any MR center and on 
any 1.5T and 3T MR scanners without the need for complicated corrections or 
calibration procedures. 
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